0ET Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Esperion Therapeutics Inc

Watchlist Manager

Watchlist

Price: 2.662 EUR 0.19% Market Closed

Market Cap: €288.4m

E	Esperion Therapeutics Inc SWB:0ET	US
C	CarGurus Inc F:0C6	US
	OMV AG SIX:OMV	AT
	Compagnie de Saint Gobain SA PAR:SGO	FR
P	PSI Software AG XBER:PSAN	DE
	Sequana Medical NV F:2SE	BE
A	Amgen Inc BMV:AMGN	US
I	ITV PLC XBER:IJ7	UK
	Five Below Inc LSE:0IPD	US
3	3M Co XHAM:MMM	US
E	Ecolab Inc F:ECJ	US
K	Konami Group Corp DUS:KOA	JP
Z	Zijin Mining Group Co Ltd F:FJZB	CN

Profitability Summary

Esperion Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

68%

Strong 3Y Average Gross Margin

70%

Gross Margin is Increasing

67% > 68%

Healthy Operating Margin

15%

Negative 3Y Average Operating Margin

-47%

Operating Margin is Increasing

-193% > 15%

Negative Net Margin

-6%

Negative 3Y Average Net Margin

-81%

Net Margin is Increasing

-253% > -6%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-54%

Free Cash Flow Margin is Increasing

-187% > -3%

Low ROE

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-56%

ROIC is Increasing

-192% > 34%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.